Virtu Financial LLC Statera Biopharma, Inc. Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 07, 2022	BUY	$0.13 - $0.28 $13,310 - $28,667	102,385 New	102,385 $13,000
Q2 2022 Aug 09, 2022	SELL	$0.21 - $0.38 $33,112 - $59,917	-157,678 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$0.31 - $2.27 $39,281 - $287,643	126,715 Added 409.25%	157,678 $50,000
Q4 2021 Feb 17, 2022	BUY	$2.01 - $4.08 $35,733 - $72,534	17,778 Added 134.84%	30,963 $71,000
Q3 2021 Nov 12, 2021	BUY	$2.29 - $6.24 $30,193 - $82,274	13,185 New	13,185 $30,000

30K

Ticker STAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,295,700
Description
Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.